Therefore, GPR109a is a factor that represents increased health and lifespan, with it showing potential to be used as a therapeutic target for the prevention of type 2 diabetes, obesity, and inflammation [25]. This evidence concerns the gene HCAR2 and type 2 diabetes mellitus.